SALIX PHARMACEUTICALS LTD Shareholders' Equity
SALIX PHARMACEUTICALS LTD had Shareholders' Equity of $238.24 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2015-03-02
- 2014-12-31: Stockholders' Equity Attributable to Parent $238.24M.
- 2014-09-30: Stockholders' Equity Attributable to Parent $517.71M; Stockholders' Equity Attributable to Parent as first filed $527.95M.
- 2014-06-30: Stockholders' Equity Attributable to Parent $729.48M; Stockholders' Equity Attributable to Parent as first filed $736.23M.
- 2014-03-31: Stockholders' Equity Attributable to Parent $708.43M; Stockholders' Equity Attributable to Parent as first filed $711.51M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2014-12-31 | $238.24M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $517.71M 10-Q/A · filed 2015-03-02 | $527.95M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $729.48M 10-Q/A · filed 2015-03-02 | $736.23M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $708.43M 10-Q/A · filed 2015-03-02 | $711.51M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $728.64M 10-K · filed 2015-03-02 | $740.87M 10-K · filed 2014-02-28 |
| 2013-09-30 | $678.48M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $619.42M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $586.68M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $560.50M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $532.60M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $504.42M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $475.33M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $549.64M 10-K · filed 2015-03-02 | |
| 2011-09-30 | $480.43M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $438.92M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $407.84M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $401.92M 10-K · filed 2015-03-02 | |
| 2009-12-31 | $370.02M 10-K · filed 2013-03-01 | |
| 2008-12-31 | $265.40M 10-K · filed 2012-02-28 |